This announcement is a separate document:
仁和药业：关于参与重组并收购通化中盛药业有限公司51%股权的公告
Renhe Pharmaceutical: Announcement on participating in the restructuring and acquisition of 51% of Tonghua Zhongsheng Pharmaceutical Co., Ltd.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.